Sponsor
K36 Therapeutics Inc.
1 Main Street 13, 02142-1517, United States
About the sponsor
Research activity is centered on relapsed and refractory multiple myeloma, with an emphasis on treatment-resistant disease in the bone marrow.
- Multiple myeloma
- Relapsed disease
- Refractory disease
The sponsor’s clinical work is directed toward patients whose disease has returned or has not responded adequately to prior cancer therapy.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.